netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Obinutuzumab found 7 matches
Open monograph to display formulary status BNF Category
  Obinutuzumab Malignant disease and immunosuppression - Anti-lymphocyte monoclonal antibodies - 08.02.03
 
Non Formulary BNF Category
  Cytotoxic Drug Zanubrutinib  (Brukinsa®) Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NHSE Clinical Commissioning Policy: Obinutuzumab elective therapy to prevent immune Thrombotic Thrombocytopenic Purpura (TTP) relapse in patients who are refractory or intolerant to rituximab (adults)  (08.02.03)
link in drug section NICE TA343: Obinutuzumab with chlorambucil for CLL (08.02.03)
link in drug section NICE TA629: Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab (08.02.03)
link in drug section NICE TA663 Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia (08.01.05)
link in drug section NICE TA978: Zanubrutinib with obinutuzumab for treating relapsed or refractory B-cell follicular lymphoma after 2 or more treatments (terminated appraisal) (08.01.05)


 
netFormulary